Logo
    Search

    CRISPR pioneer Doudna envisions ending asthma, aiding climate

    enOctober 23, 2023

    Podcast Summary

    • Applying CRISPR to complex problems like childhood asthma through microbiome manipulationCRISPR technology is being used to prevent childhood asthma by eliminating disease-causing molecules from the microbiome, but the process is complex and timeline uncertain due to high risks and potential rewards, with affordability and accessibility being top priorities.

      CRISPR gene editing technology, discovered a decade ago by Nobel Laureate Jennifer Doudna, is being applied to complex problems like chronic diseases, specifically childhood asthma, by manipulating the microbiome. However, the process is challenging due to the complexity of microbiomes and the need to manipulate various genes at different times. The goal is to prevent asthma by eliminating disease-causing molecules emitted by the microbiome. While the aim is to make clinical progress within 7 years, the timeline is uncertain due to the high risks and potential high rewards of such projects. Another important consideration is affordability and accessibility of genome editing technology, which is a top priority for researchers in the field.

    • CRISPR's Focus Shifts to Scaling Up and Making it AffordableCRISPR technology, initially for sickle cell disease, is now expanding to target microbiomes and metagenomics, with UC Berkeley's Innovative Genomics Institute leading interdisciplinary collaborations to make it more accessible and affordable.

      CRISPR technology, on the brink of its first approval for sickle cell disease treatment, is now focusing on scaling up and making it more affordable and accessible to expand its impact. This was not the initial application Jennifer Doudna had in mind when she started working on CRISPR 13 years ago. The technology's versatility and constant advancements have led to new opportunities, such as targeting microbiomes and combining it with metagenomics. The UC Berkeley's Innovative Genomics Institute, where Doudna works, is a perfect example of interdisciplinary collaboration, bringing together experts from various fields to push the boundaries of science. The institute's merging of two labs, working on fundamental CRISPR aspects and metagenomics, is an exciting development that could lead to significant advancements in the field.

    • Identifying organisms at the DNA level without isolation played a crucial role in COVID testsEffective teamwork is essential in academic organizations to align bright minds towards a common goal, as demonstrated during the pandemic by the Innovative Genomics Institute.

      Jill Banfield's lab, which specializes in identifying organisms at the DNA level without isolation, played a crucial role in providing over 600,000 saliva-based COVID tests during the pandemic in Northern California. This experience taught them the importance of effective teamwork, especially in academic organizations where attracting bright minds to work on big problems is common but aligning them towards a common goal can be a challenge. The Innovative Genomics Institute's success in fostering teamwork during the pandemic is now being applied to other areas, including the expansion of opportunities with CRISPR technology.

    • Importance of collaboration in CRISPR researchBuilding expert teams and merging CRISPR data with AI can lead to valuable gene function insights, despite ethical debates.

      Collaborative work is essential in scientific research, especially when dealing with complex technologies like CRISPR-Cas9 gene editing. However, this goes against the individualistic culture deeply ingrained in academia. Dr. Jennifer Doudna from UC Berkeley emphasizes the importance of building teams of experts with complementary skill sets to tackle the challenges posed by CRISPR. Moreover, she highlights the potential of merging CRISPR's vast genetic data with machine learning and artificial intelligence to gain valuable insights into gene function. Despite the ethical dilemmas surrounding CRISPR, the ongoing debate and research efforts aim to ensure safer and more precise applications of this groundbreaking technology.

    • Exploring CRISPR for methane reduction and sickle cell disease treatmentCRISPR technology is being investigated for methane reduction in cows and sickle cell disease treatment, potentially setting precedents for FDA's gene editing regulations.

      CRISPR technology is being explored for various applications beyond just medical treatments. One such application is reducing methane emissions from cow burps. The plan is to modify the microbiomes of cows at birth to decrease methane production throughout their lives. The Food and Drug Administration (FDA) is currently considering a CRISPR-based treatment for sickle cell disease, which could serve as a significant test case for how the FDA approaches gene editing technology. Meanwhile, for kids looking to understand complex financial concepts, the Million Bazillion podcast from Marketplace offers engaging and informative answers to their questions about money. Episodes cover topics like college accounts, unions, and even the role of gold in the economy.

    Recent Episodes from Marketplace Tech

    Bytes: Week in Review — music biz vs. AI, social media moderation and Nvidia stock woes

    Bytes: Week in Review — music biz vs. AI, social media moderation and Nvidia stock woes

    In the past week or so, Nvidia’s stock finally encountered the law of gravity — what goes up must eventually come down, at least a little bit. And we look under the hood of artificial intelligence companies that aren’t necessarily making headlines. Plus, the Supreme Court ruled against Republican-led states that accused the federal government of coercing social media companies into suppressing content. But first, major music labels, including Universal, Sony and Warner, are suing two startups that produce AI-generated music. The labels accuse Suno and Udio of using copyrighted works scraped from the internet to train their AI models. Marketplace’s Lily Jamali speaks with Anita Ramaswamy, columnist at The Information, for her takes on these stories in this week’s Marketplace Tech Bytes: Week in Review.

    Marketplace Tech
    enJune 28, 2024

    The evolution of political messaging into the digital age

    The evolution of political messaging into the digital age

    It feels like eons ago, but during a town hall on violence in America in 1994, then-President Bill Clinton took to MTV to reach the nation’s youth. Clinton’s openness to MTV and what The New York Times called “other unconventional media” had helped pave his path to the White House two years earlier. Fast-forward to today, and even reluctant politicians use TikTok to reach younger voters — President Joe Biden is no exception. His first post came just ahead of this year’s Super Bowl. We invited Marketplace’s senior Washington correspondent, Kimberly Adams, and Joshua Scacco, professor of political communication and director of the Center for Sustainable Democracy at the University of South Florida, to discuss the evolution of political messaging with Marketplace’s Lily Jamali. Scacco said Clinton’s MTV moment informed how future presidents, including his successor, George W. Bush, have engaged with Americans.

    Marketplace Tech
    enJune 27, 2024

    How data generated by everyday apps can incriminate abortion seekers

    How data generated by everyday apps can incriminate abortion seekers

    This week, we’ve been taking stock of how tech has both helped and harmed Americans trying to get abortions in the two years since the U.S. Supreme Court overturned Roe v. Wade. After the Dobbs decision, some experts warned consumers that menstrual tracking apps would provide a means of surveilling abortion seekers. There was even a social media campaign on what was then Twitter advising people to delete their period trackers. But it’s turned out that the threat to privacy isn’t limited to those apps. Other digital data can actually be more likely to reveal an illegal abortion. That’s according to Albert Fox Cahn, founder of the Surveillance Technology Oversight Project. He told Marketplace’s Lily Jamali that everyday consumer apps generate sensitive data that can be used for abortion surveillance.

     

    Marketplace Tech
    enJune 26, 2024

    Protecting abortion patients’ digital data in the post-Roe era

    Protecting abortion patients’ digital data in the post-Roe era

    After the U.S. Supreme Court took away the federal right to abortion two years ago, telehealth has helped provide ongoing access, including to people in states where abortion is now banned. That was our subject Monday. Now we are looking into apps that link patients with abortion providers. Julie F. Kay, executive director at the Abortion Coalition for Telemedicine, told Marketplace’s Lily Jamali that digital privacy protections are far from equal across these services.

    Marketplace Tech
    enJune 25, 2024

    Telehealth widens access to abortion care as lawmakers restrict it

    Telehealth widens access to abortion care as lawmakers restrict it

    Two years ago this week, the Supreme Court ruled that abortions are not constitutionally protected in the U.S., a decision that would draw protests across the country. Since then, 14 states have outlawed abortions. Still, some people in those states have been able to cut through barriers to get abortions via telehealth, according to a recent report from the research project #WeCount. Usually, this requires a virtual visit with a telehealth care provider. The provider assesses the patient and gets their information, then can mail them mifepristone and misoprostol, which aid in ending a pregnancy. The Supreme Court preserved access to mifepristone in a ruling this month, which means it can still be prescribed and mailed to patients. Marketplace’s Lily Jamali discussed the increase in telehealth abortions with Ushma Upadhyay, professor of OB-GYN and reproductive sciences at the University of California, San Francisco, and a coauthor of the #WeCount report.

    Marketplace Tech
    enJune 24, 2024

    Bytes: Week in Review — Warning labels for social media, Adobe’s hidden fees and a less open OpenAI

    Bytes: Week in Review — Warning labels for social media, Adobe’s hidden fees and a less open OpenAI

    Big Tech subscription services are once again in the crosshairs of the Federal Trade Commission, nonprofits with links to OpenAI are becoming less transparent, and Surgeon General Vivek Murthy is urging Congress to require warning labels on social media. Marketplace’s Lily Jamali speaks with Paresh Dave, senior writer at Wired magazine, for this week’s Tech Bytes: Week in Review

    Marketplace Tech
    enJune 21, 2024

    2014: The year that shaped social media

    2014: The year that shaped social media

    Picture this: The year is 2014. The song “Happy” by Pharrell Williams is playing on every top 100 station, and the Ellen DeGeneres star-studded Oscars selfie has just “broken Twitter.” As all of this is happening, a bunch of content creators in certain corners of social media are about to start making a whole lot of money. Culture reporter Steffi Cao recently wrote in The Ringer that 2014 was the year that shaped the internet we know today. Marketplace’s Lily Jamali spoke to her about what happened online 10 years ago.

    Marketplace Tech
    enJune 20, 2024

    Juneteenth’s viral moment and its future

    Juneteenth’s viral moment and its future

    Shortly after the Union won the Civil War in 1865, a union major general issued an order: “The people of Texas are informed that, in accordance with a proclamation from the Executive of the United States, all slaves are free.” June 19, known as Juneteenth, has long been celebrated by African Americans. But in 2020, in the thick of the Covid-19 pandemic and the protests that followed the murder of George Floyd, Juneteenth took the internet by storm. Marketplace’s Lily Jamali spoke with Brandon Ogbunu, professor in the Department of Ecology and Evolutionary Biology at Yale, who wrote about that moment for WIRED back then. He revisited what was happening at that time a year before Juneteenth became a national holiday.

    Marketplace Tech
    enJune 19, 2024

    Meet the man who combines science, technology and magic to understand proteins

    Meet the man who combines science, technology and magic to understand proteins

    Marketplace’s Lily Jamali recently visited the headquarters of Nautilus Biotechnology to meet with Parag Mallick, the company’s founder and chief scientist, who is also a magician and an associate professor at Stanford University. Since 2016, Mallick and his team have been building a machine that they say will revolutionize biomedicine by unlocking the secrets of the “dark proteome.”

    Marketplace Tech
    enJune 18, 2024

    How to find a mailbox in Sao Paulo’s favelas

    How to find a mailbox in Sao Paulo’s favelas

    Brazil has densely populated low-income communities living on the outskirts of many cities like Rio de Janeiro and Sao Paulo. Ordering online shopping just isn’t an option for residents as these towns don’t have an official address, but that may be changing. The BBC’s Ben Derico reports.

    Marketplace Tech
    enJune 17, 2024

    Related Episodes

    What happens when human beings take control of their own evolution?

    What happens when human beings take control of their own evolution?
    Over the past decade, scientists have developed what was once just the subject of dystopian fiction: gene editing technology. It's known as CRISPR. Jennifer Doudna, a professor of molecular and cell biology and chemistry at the University of California Berkeley, was a key member of the research group that developed the technology. She's also the co-author of the recent book A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. A straightforward description of CRISPR is mind-boggling in what it suggests. As Doudna writes, “the genome — an organism’s entire DNA content, including all its genes — has become almost as editable as a simple piece of text.” It is possible that when the history of this era is written, most of our obsessions — Trump, tax rates, cybersecurity, Obamacare, NFL protests — will be forgotten, and CRISPR will be where historians focus. With great power comes great responsibility — and genuine terror. Doudna had a nightmare as her lab and others started to use CRISPR to make heritable changes in genes. She dreamed that her colleague wanted her to meet someone interested in her research — and it was Adolf Hitler with a pig face, waiting to take notes on the technology she developed. She awoke from that dream in a cold sweat. And the concerns that dream represent pushed her to discuss the implications of CRISPR technology publicly. CRISPR could do enormous good or tremendous harm — or both. In this conversation, Doudna and I discuss its possibilities, its dangers, its technical obstacles, the regulatory questions it raises, and much more. Books: The Double Helix by Jim Watson Sapiens: A Brief History of Humankind by Yuval Noah Harari The Making of the Atomic Bomb by Richard Rhodes Learn more about your ad choices. Visit podcastchoices.com/adchoices

    Tracking the rapid rise of human-enhancing biotech with Siddhartha Mukherjee

    Tracking the rapid rise of human-enhancing biotech with Siddhartha Mukherjee
    In the past decade, we’ve seen an explosion in medical and biotechnologies like gene editing with CRISPR, synthetic organs, cloning, and AI-powered prosthetics that are helping to eradicate disease, improve the human condition, and enhance our brain power. These developments have radically transformed our understanding of the human body and what we thought was possible. But like most new tech, there’s also potential for misuse, privacy concerns, and ethical implications. Gene editing can cure debilitating diseases but also lead to designer babies. AI learning algorithms can power neural implants but also potentially create new chemical weapons. 
     
    Ian Bremmer delves into that tension on the GZERO World Podcast with Siddhartha Mukherjee, a physician and biologist whose new book, “The Song of the Cell,” explores the science, history, and technology behind what he calls “the new humans.”
     

    Ep#012: Personalization in Reproductive Medicine in the Era of CRISPR/Cas9 with Dr. Helen O'Neill

    Ep#012: Personalization in Reproductive Medicine in the Era of CRISPR/Cas9 with Dr. Helen O'Neill
    In Episode 12, we discuss the progress of personalization in the field of reproductive medicine with our guest Dr. Helen O'Neill. Helen is a Lecturer in Reproductive and Molecular Genetics and Director for the MSc Program in Reproductive Science and Women’s Health at the Institute for Women’s Health, University College London. She has over 10 years of experience as a researcher and science communicator on various topics of reproductive medicine, genome editing, and women’s health. Beyond her work as an academic, she recently co-founded Hertility Health with the aim to change the face of women’s health.

    Our host Luisa talked to Helen about:

    ◦ The importance of reproductive health
    ◦ The power of genome editing
    ◦ CRISPR as a collection of technologies
    ◦ Ethical concerns around genome editing
    ◦ Using sequencing to examine embryo development
    ◦ Gene editing in clinical settings
    ◦ Start-up story of Hertility Health
    ◦ Why women's health research is still in its infancy
    ◦ The need for open science communication
    ◦ Including men in fertility education
    ◦ Launching a start-up during COVID-19
    ◦ Improving women's health through more research
    ◦ The future of personalized medicine in reproductive health

    Get in touch with Helen:
    UCL Iris profile: Helen O Neill
    Twitter: @DrHelenONeill
    LinkedIn: Dr Helen O' Neill
    Instagram @dr.helenoneill
    Web: https://hertilityhealth.com/

    Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com

    #52 Bacteria and antibiotics – who’s the bad guy?

    #52 Bacteria and antibiotics – who’s the bad guy?

    Martin Blaser, professor of medicine and microbiology at New York University, has a theory about why humanity is getting fatter. He believes that some of our modern medical practices are to blame. The main culprit? Antibiotics – or rather, the way we have abused these antibacterial drugs over the last 70 years. Each one of us hosts a collection of good bacteria, known as the microbiome, that keep us healthy by training our immune system, helping us digest food and making essential vitamins for us. In this episode, Martin Blaser explains how this useful alliance is perturbed when we take antibiotics. Who would have guessed that the same ‘miracle drugs’ that cure us from horrible, deadly infections would – in some ways – make us sicker?